Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Interactions of ET-26-HCl in Healthy Subjects
NCT06822166Phase 1Completed
- Sponsor
- Jinzhou Ahon Pharmaceutical Co., Ltd.
- Start
- Dec 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of methoxyethyl etomidate in general anesthesia (3 arms), sponsored by Jinzhou Ahon Pharmaceutical Co., Ltd. Primary endpoint: Pharmacokinetic Parameter (ET-26/etomidate acid). Started Dec 2023; status: completed.
02
Drugs
methoxyethyl etomidate
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT06822166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06822166.